White Papers
Ingenix® Suite Lab Data & Device Management Software
Optimize Lab Efficiency, Accuracy, and Compliance for Electronic Pipettes and Lab Balances
Transform your cell culture media and bioprocess with cQrex® peptides- Please access our latest whitepaper now!
Unlock the potential of your bioprocess with Evonik's innovative cQrex® ingredients, to gain higher productivity and high efficiency in biopharmaceuticals manufacturing
Whitepaper: Qual Tark biopharma ecosystem
Learn how the curated QualTrak offering of qPCR and dPCR instruments, reagents, and assays can help streamline biologics development.
Whitepaper: Qual Tark biopharma ecosystem
Learn how the curated QualTrak offering of qPCR and dPCR instruments, reagents, and assays can help streamline biologics development.
A new study reveals substantial efficiency gains
The pharmaceutical and biotechnology industries are at a crossroads. Escalating development costs, new modalities, increasing scientific and logistical demands, regulatory complexity, and mounting pressure to accelerate timelines are creating unprecedented challenges for drug developers.
Advancements in Biopharma: Enhancing Drug Development with Thermo Fisher Scientific’s qPCR Solutions
The biopharma industry is rapidly advancing, with the cell and gene therapy (CGT) market valued at $18 billion, including 27 approved gene therapies, 65 approved cell therapies, and 26 RNA therapies as of 2023.
Applications for qPCR in therapeutic monoclonal antibody development and manufacturing
Monoclonal antibodies are immunoglobulins produced in a laboratory setting that bind to specific antigens, such as epitopes expressed on the surfaces of cells. They can be used to treat various diseases, including some forms of cancer.
Updated requirements on balances for the pharmaceutical industry: Current status from USP, Ph.Eur., JP, ChP
This white paper summarizes what has changed with the latest revisions in the major global standards,United States Pharmacopeia (USP), European Pharmacopoeia (Ph.Eur.), Japanese Pharmacopoeia (JP), and Chinese Pharmacopoeia (ChP).
Strengthen Container Closure Integrity Across the Drug Product Lifecycle
Maintaining container closure integrity (CCI) is essential to ensure the safety, quality, and efficacy of sterile drug products.
Accelerate Tox Material Delivery and Stay on Track for IND Submission
As development timelines tighten, generating toxicology (tox) data quickly has become a critical milestone on the path to IND submission.
